Report Overview
Migraines are a family of recurrent attacks.The symptom is paroxysmal unilateral throbbing headache, accompanied by nausea, vomiting and confusion. Migraine therapeutics includes triptans, acetylcholine inhibitors/neurotoxins, ergot alkaloids, nsaids, ditan, CGRP small molecule antagonists, CGRP monoclonal antibodies, etc.
This report provides a deep insight into the global Migraine Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Migraine Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Migraine Therapeutics market in any manner.
Global Migraine Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Allergan
Merck
Pfizer
Teva
Amgen
Johnson & Johnson
Endo International
GlaxoSmithKline
Impax
Abbott
Bayer
Eli Lilly
Novartis International
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
AstraZeneca
Amirall
OptiNose
Revance Therapeutics
RedHill Biopharma
Bausch Health
NeurAxon
Biohaven Pharma
Eisai
Valeant Pharma
Market Segmentation (by Type)
Specific Anti-migraine Drugs
Acute Therapies
Preventative Therapies
Other
Market Segmentation (by Application)
Hospitals
Clinics
Household Use
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Migraine Therapeutics Market
? Overview of the regional outlook of the Migraine Therapeutics Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Migraine Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Migraine Therapeutics
1.2 Key Market Segments
1.2.1 Migraine Therapeutics Segment by Type
1.2.2 Migraine Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Migraine Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Migraine Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Migraine Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Migraine Therapeutics Market Competitive Landscape
3.1 Global Migraine Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Migraine Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Migraine Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Migraine Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Migraine Therapeutics Sales Sites, Area Served, Product Type
3.6 Migraine Therapeutics Market Competitive Situation and Trends
3.6.1 Migraine Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Migraine Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Migraine Therapeutics Industry Chain Analysis
4.1 Migraine Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Migraine Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Migraine Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Migraine Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Migraine Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Migraine Therapeutics Price by Type (2019-2024)
7 Migraine Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Migraine Therapeutics Market Sales by Application (2019-2024)
7.3 Global Migraine Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Migraine Therapeutics Sales Growth Rate by Application (2019-2024)
8 Migraine Therapeutics Market Segmentation by Region
8.1 Global Migraine Therapeutics Sales by Region
8.1.1 Global Migraine Therapeutics Sales by Region
8.1.2 Global Migraine Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Migraine Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Migraine Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Migraine Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Migraine Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Migraine Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Allergan
9.1.1 Allergan Migraine Therapeutics Basic Information
9.1.2 Allergan Migraine Therapeutics Product Overview
9.1.3 Allergan Migraine Therapeutics Product Market Performance
9.1.4 Allergan Business Overview
9.1.5 Allergan Migraine Therapeutics SWOT Analysis
9.1.6 Allergan Recent Developments
9.2 Merck
9.2.1 Merck Migraine Therapeutics Basic Information
9.2.2 Merck Migraine Therapeutics Product Overview
9.2.3 Merck Migraine Therapeutics Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Migraine Therapeutics SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Pfizer
9.3.1 Pfizer Migraine Therapeutics Basic Information
9.3.2 Pfizer Migraine Therapeutics Product Overview
9.3.3 Pfizer Migraine Therapeutics Product Market Performance
9.3.4 Pfizer Migraine Therapeutics SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Teva
9.4.1 Teva Migraine Therapeutics Basic Information
9.4.2 Teva Migraine Therapeutics Product Overview
9.4.3 Teva Migraine Therapeutics Product Market Performance
9.4.4 Teva Business Overview
9.4.5 Teva Recent Developments
9.5 Amgen
9.5.1 Amgen Migraine Therapeutics Basic Information
9.5.2 Amgen Migraine Therapeutics Product Overview
9.5.3 Amgen Migraine Therapeutics Product Market Performance
9.5.4 Amgen Business Overview
9.5.5 Amgen Recent Developments
9.6 Johnson and Johnson
9.6.1 Johnson and Johnson Migraine Therapeutics Basic Information
9.6.2 Johnson and Johnson Migraine Therapeutics Product Overview
9.6.3 Johnson and Johnson Migraine Therapeutics Product Market Performance
9.6.4 Johnson and Johnson Business Overview
9.6.5 Johnson and Johnson Recent Developments
9.7 Endo International
9.7.1 Endo International Migraine Therapeutics Basic Information
9.7.2 Endo International Migraine Therapeutics Product Overview
9.7.3 Endo International Migraine Therapeutics Product Market Performance
9.7.4 Endo International Business Overview
9.7.5 Endo International Recent Developments
9.8 GlaxoSmithKline
9.8.1 GlaxoSmithKline Migraine Therapeutics Basic Information
9.8.2 GlaxoSmithKline Migraine Therapeutics Product Overview
9.8.3 GlaxoSmithKline Migraine Therapeutics Product Market Performance
9.8.4 GlaxoSmithKline Business Overview
9.8.5 GlaxoSmithKline Recent Developments
9.9 Impax
9.9.1 Impax Migraine Therapeutics Basic Information
9.9.2 Impax Migraine Therapeutics Product Overview
9.9.3 Impax Migraine Therapeutics Product Market Performance
9.9.4 Impax Business Overview
9.9.5 Impax Recent Developments
9.10 Abbott
9.10.1 Abbott Migraine Therapeutics Basic Information
9.10.2 Abbott Migraine Therapeutics Product Overview
9.10.3 Abbott Migraine Therapeutics Product Market Performance
9.10.4 Abbott Business Overview
9.10.5 Abbott Recent Developments
9.11 Bayer
9.11.1 Bayer Migraine Therapeutics Basic Information
9.11.2 Bayer Migraine Therapeutics Product Overview
9.11.3 Bayer Migraine Therapeutics Product Market Performance
9.11.4 Bayer Business Overview
9.11.5 Bayer Recent Developments
9.12 Eli Lilly
9.12.1 Eli Lilly Migraine Therapeutics Basic Information
9.12.2 Eli Lilly Migraine Therapeutics Product Overview
9.12.3 Eli Lilly Migraine Therapeutics Product Market Performance
9.12.4 Eli Lilly Business Overview
9.12.5 Eli Lilly Recent Developments
9.13 Novartis International
9.13.1 Novartis International Migraine Therapeutics Basic Information
9.13.2 Novartis International Migraine Therapeutics Product Overview
9.13.3 Novartis International Migraine Therapeutics Product Market Performance
9.13.4 Novartis International Business Overview
9.13.5 Novartis International Recent Developments
9.14 Ethypharm
9.14.1 Ethypharm Migraine Therapeutics Basic Information
9.14.2 Ethypharm Migraine Therapeutics Product Overview
9.14.3 Ethypharm Migraine Therapeutics Product Market Performance
9.14.4 Ethypharm Business Overview
9.14.5 Ethypharm Recent Developments
9.15 Kowa Pharmaceuticals America
9.15.1 Kowa Pharmaceuticals America Migraine Therapeutics Basic Information
9.15.2 Kowa Pharmaceuticals America Migraine Therapeutics Product Overview
9.15.3 Kowa Pharmaceuticals America Migraine Therapeutics Product Market Performance
9.15.4 Kowa Pharmaceuticals America Business Overview
9.15.5 Kowa Pharmaceuticals America Recent Developments
9.16 Winston Pharmaceuticals
9.16.1 Winston Pharmaceuticals Migraine Therapeutics Basic Information
9.16.2 Winston Pharmaceuticals Migraine Therapeutics Product Overview
9.16.3 Winston Pharmaceuticals Migraine Therapeutics Product Market Performance
9.16.4 Winston Pharmaceuticals Business Overview
9.16.5 Winston Pharmaceuticals Recent Developments
9.17 AstraZeneca
9.17.1 AstraZeneca Migraine Therapeutics Basic Information
9.17.2 AstraZeneca Migraine Therapeutics Product Overview
9.17.3 AstraZeneca Migraine Therapeutics Product Market Performance
9.17.4 AstraZeneca Business Overview
9.17.5 AstraZeneca Recent Developments
9.18 Amirall
9.18.1 Amirall Migraine Therapeutics Basic Information
9.18.2 Amirall Migraine Therapeutics Product Overview
9.18.3 Amirall Migraine Therapeutics Product Market Performance
9.18.4 Amirall Business Overview
9.18.5 Amirall Recent Developments
9.19 OptiNose
9.19.1 OptiNose Migraine Therapeutics Basic Information
9.19.2 OptiNose Migraine Therapeutics Product Overview
9.19.3 OptiNose Migraine Therapeutics Product Market Performance
9.19.4 OptiNose Business Overview
9.19.5 OptiNose Recent Developments
9.20 Revance Therapeutics
9.20.1 Revance Therapeutics Migraine Therapeutics Basic Information
9.20.2 Revance Therapeutics Migraine Therapeutics Product Overview
9.20.3 Revance Therapeutics Migraine Therapeutics Product Market Performance
9.20.4 Revance Therapeutics Business Overview
9.20.5 Revance Therapeutics Recent Developments
9.21 RedHill Biopharma
9.21.1 RedHill Biopharma Migraine Therapeutics Basic Information
9.21.2 RedHill Biopharma Migraine Therapeutics Product Overview
9.21.3 RedHill Biopharma Migraine Therapeutics Product Market Performance
9.21.4 RedHill Biopharma Business Overview
9.21.5 RedHill Biopharma Recent Developments
9.22 Bausch Health
9.22.1 Bausch Health Migraine Therapeutics Basic Information
9.22.2 Bausch Health Migraine Therapeutics Product Overview
9.22.3 Bausch Health Migraine Therapeutics Product Market Performance
9.22.4 Bausch Health Business Overview
9.22.5 Bausch Health Recent Developments
9.23 NeurAxon
9.23.1 NeurAxon Migraine Therapeutics Basic Information
9.23.2 NeurAxon Migraine Therapeutics Product Overview
9.23.3 NeurAxon Migraine Therapeutics Product Market Performance
9.23.4 NeurAxon Business Overview
9.23.5 NeurAxon Recent Developments
9.24 Biohaven Pharma
9.24.1 Biohaven Pharma Migraine Therapeutics Basic Information
9.24.2 Biohaven Pharma Migraine Therapeutics Product Overview
9.24.3 Biohaven Pharma Migraine Therapeutics Product Market Performance
9.24.4 Biohaven Pharma Business Overview
9.24.5 Biohaven Pharma Recent Developments
9.25 Eisai
9.25.1 Eisai Migraine Therapeutics Basic Information
9.25.2 Eisai Migraine Therapeutics Product Overview
9.25.3 Eisai Migraine Therapeutics Product Market Performance
9.25.4 Eisai Business Overview
9.25.5 Eisai Recent Developments
9.26 Valeant Pharma
9.26.1 Valeant Pharma Migraine Therapeutics Basic Information
9.26.2 Valeant Pharma Migraine Therapeutics Product Overview
9.26.3 Valeant Pharma Migraine Therapeutics Product Market Performance
9.26.4 Valeant Pharma Business Overview
9.26.5 Valeant Pharma Recent Developments
10 Migraine Therapeutics Market Forecast by Region
10.1 Global Migraine Therapeutics Market Size Forecast
10.2 Global Migraine Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Migraine Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Migraine Therapeutics Market Size Forecast by Region
10.2.4 South America Migraine Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Migraine Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Migraine Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Migraine Therapeutics by Type (2025-2030)
11.1.2 Global Migraine Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Migraine Therapeutics by Type (2025-2030)
11.2 Global Migraine Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Migraine Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Migraine Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Migraine Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Migraine Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Migraine Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Migraine Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Migraine Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Therapeutics as of 2022)
Table 10. Global Market Migraine Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Migraine Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Migraine Therapeutics Product Type
Table 13. Global Migraine Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Migraine Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Migraine Therapeutics Market Challenges
Table 22. Global Migraine Therapeutics Sales by Type (K Units)
Table 23. Global Migraine Therapeutics Market Size by Type (M USD)
Table 24. Global Migraine Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Migraine Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Migraine Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Migraine Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Migraine Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Migraine Therapeutics Sales (K Units) by Application
Table 30. Global Migraine Therapeutics Market Size by Application
Table 31. Global Migraine Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Migraine Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Migraine Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Migraine Therapeutics Market Share by Application (2019-2024)
Table 35. Global Migraine Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Migraine Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Migraine Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Migraine Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Migraine Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Migraine Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Migraine Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Migraine Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Allergan Migraine Therapeutics Basic Information
Table 44. Allergan Migraine Therapeutics Product Overview
Table 45. Allergan Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Allergan Business Overview
Table 47. Allergan Migraine Therapeutics SWOT Analysis
Table 48. Allergan Recent Developments
Table 49. Merck Migraine Therapeutics Basic Information
Table 50. Merck Migraine Therapeutics Product Overview
Table 51. Merck Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Migraine Therapeutics SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Pfizer Migraine Therapeutics Basic Information
Table 56. Pfizer Migraine Therapeutics Product Overview
Table 57. Pfizer Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pfizer Migraine Therapeutics SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Teva Migraine Therapeutics Basic Information
Table 62. Teva Migraine Therapeutics Product Overview
Table 63. Teva Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Teva Business Overview
Table 65. Teva Recent Developments
Table 66. Amgen Migraine Therapeutics Basic Information
Table 67. Amgen Migraine Therapeutics Product Overview
Table 68. Amgen Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Amgen Business Overview
Table 70. Amgen Recent Developments
Table 71. Johnson and Johnson Migraine Therapeutics Basic Information
Table 72. Johnson and Johnson Migraine Therapeutics Product Overview
Table 73. Johnson and Johnson Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Johnson and Johnson Business Overview
Table 75. Johnson and Johnson Recent Developments
Table 76. Endo International Migraine Therapeutics Basic Information
Table 77. Endo International Migraine Therapeutics Product Overview
Table 78. Endo International Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Endo International Business Overview
Table 80. Endo International Recent Developments
Table 81. GlaxoSmithKline Migraine Therapeutics Basic Information
Table 82. GlaxoSmithKline Migraine Therapeutics Product Overview
Table 83. GlaxoSmithKline Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Recent Developments
Table 86. Impax Migraine Therapeutics Basic Information
Table 87. Impax Migraine Therapeutics Product Overview
Table 88. Impax Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Impax Business Overview
Table 90. Impax Recent Developments
Table 91. Abbott Migraine Therapeutics Basic Information
Table 92. Abbott Migraine Therapeutics Product Overview
Table 93. Abbott Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Abbott Business Overview
Table 95. Abbott Recent Developments
Table 96. Bayer Migraine Therapeutics Basic Information
Table 97. Bayer Migraine Therapeutics Product Overview
Table 98. Bayer Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Bayer Business Overview
Table 100. Bayer Recent Developments
Table 101. Eli Lilly Migraine Therapeutics Basic Information
Table 102. Eli Lilly Migraine Therapeutics Product Overview
Table 103. Eli Lilly Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Eli Lilly Business Overview
Table 105. Eli Lilly Recent Developments
Table 106. Novartis International Migraine Therapeutics Basic Information
Table 107. Novartis International Migraine Therapeutics Product Overview
Table 108. Novartis International Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Novartis International Business Overview
Table 110. Novartis International Recent Developments
Table 111. Ethypharm Migraine Therapeutics Basic Information
Table 112. Ethypharm Migraine Therapeutics Product Overview
Table 113. Ethypharm Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Ethypharm Business Overview
Table 115. Ethypharm Recent Developments
Table 116. Kowa Pharmaceuticals America Migraine Therapeutics Basic Information
Table 117. Kowa Pharmaceuticals America Migraine Therapeutics Product Overview
Table 118. Kowa Pharmaceuticals America Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Kowa Pharmaceuticals America Business Overview
Table 120. Kowa Pharmaceuticals America Recent Developments
Table 121. Winston Pharmaceuticals Migraine Therapeutics Basic Information
Table 122. Winston Pharmaceuticals Migraine Therapeutics Product Overview
Table 123. Winston Pharmaceuticals Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Winston Pharmaceuticals Business Overview
Table 125. Winston Pharmaceuticals Recent Developments
Table 126. AstraZeneca Migraine Therapeutics Basic Information
Table 127. AstraZeneca Migraine Therapeutics Product Overview
Table 128. AstraZeneca Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. AstraZeneca Business Overview
Table 130. AstraZeneca Recent Developments
Table 131. Amirall Migraine Therapeutics Basic Information
Table 132. Amirall Migraine Therapeutics Product Overview
Table 133. Amirall Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Amirall Business Overview
Table 135. Amirall Recent Developments
Table 136. OptiNose Migraine Therapeutics Basic Information
Table 137. OptiNose Migraine Therapeutics Product Overview
Table 138. OptiNose Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. OptiNose Business Overview
Table 140. OptiNose Recent Developments
Table 141. Revance Therapeutics Migraine Therapeutics Basic Information
Table 142. Revance Therapeutics Migraine Therapeutics Product Overview
Table 143. Revance Therapeutics Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Revance Therapeutics Business Overview
Table 145. Revance Therapeutics Recent Developments
Table 146. RedHill Biopharma Migraine Therapeutics Basic Information
Table 147. RedHill Biopharma Migraine Therapeutics Product Overview
Table 148. RedHill Biopharma Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. RedHill Biopharma Business Overview
Table 150. RedHill Biopharma Recent Developments
Table 151. Bausch Health Migraine Therapeutics Basic Information
Table 152. Bausch Health Migraine Therapeutics Product Overview
Table 153. Bausch Health Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Bausch Health Business Overview
Table 155. Bausch Health Recent Developments
Table 156. NeurAxon Migraine Therapeutics Basic Information
Table 157. NeurAxon Migraine Therapeutics Product Overview
Table 158. NeurAxon Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. NeurAxon Business Overview
Table 160. NeurAxon Recent Developments
Table 161. Biohaven Pharma Migraine Therapeutics Basic Information
Table 162. Biohaven Pharma Migraine Therapeutics Product Overview
Table 163. Biohaven Pharma Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Biohaven Pharma Business Overview
Table 165. Biohaven Pharma Recent Developments
Table 166. Eisai Migraine Therapeutics Basic Information
Table 167. Eisai Migraine Therapeutics Product Overview
Table 168. Eisai Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Eisai Business Overview
Table 170. Eisai Recent Developments
Table 171. Valeant Pharma Migraine Therapeutics Basic Information
Table 172. Valeant Pharma Migraine Therapeutics Product Overview
Table 173. Valeant Pharma Migraine Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Valeant Pharma Business Overview
Table 175. Valeant Pharma Recent Developments
Table 176. Global Migraine Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 177. Global Migraine Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 178. North America Migraine Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 179. North America Migraine Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 180. Europe Migraine Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 181. Europe Migraine Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 182. Asia Pacific Migraine Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 183. Asia Pacific Migraine Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 184. South America Migraine Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 185. South America Migraine Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 186. Middle East and Africa Migraine Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 187. Middle East and Africa Migraine Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 188. Global Migraine Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 189. Global Migraine Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 190. Global Migraine Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 191. Global Migraine Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 192. Global Migraine Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Migraine Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Migraine Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Migraine Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Migraine Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Migraine Therapeutics Market Size by Country (M USD)
Figure 11. Migraine Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Migraine Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Migraine Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Migraine Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Migraine Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Migraine Therapeutics Market Share by Type
Figure 18. Sales Market Share of Migraine Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Migraine Therapeutics by Type in 2023
Figure 20. Market Size Share of Migraine Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Migraine Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Migraine Therapeutics Market Share by Application
Figure 24. Global Migraine Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Migraine Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Migraine Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Migraine Therapeutics Market Share by Application in 2023
Figure 28. Global Migraine Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Migraine Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Migraine Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Migraine Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Migraine Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Migraine Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Migraine Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Migraine Therapeutics Sales Market Share by Region in 2023
Figure 44. China Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Migraine Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Migraine Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Migraine Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Migraine Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Migraine Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Migraine Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Migraine Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Migraine Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Migraine Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Migraine Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Migraine Therapeutics Market Share Forecast by Application (2025-2030)
